Cite
APA Citation
Zhou, C., Wang, M., Cheng, Y., Chen, Y., Zhao, Y., Shi, Y., Ahn, M., Lu, Y., Shi, M., Han, J., Kim, S., Zhang, H., Chen, G., Li, H., Wang, J., & Wu, Y. (n.d.). 511PAURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095517293.0x00003c